The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid

Background: Acetylsalicylic acid (ASA) is part of the recommended treatment of Kawasaki disease (KD). Controversies remain regarding the optimal dose of ASA. We aimed to evaluate the impact of different doses of ASA on inflammation control while minimizing adverse effects in the acute phase treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Jung Eun, Roh, Da Eun, Kim, Yeo Hyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602855/
https://www.ncbi.nlm.nih.gov/pubmed/33081227
http://dx.doi.org/10.3390/children7100185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602855/
https://www.ncbi.nlm.nih.gov/pubmed/33081227
http://dx.doi.org/10.3390/children7100185

Ejemplares similares